Smoking Cessation News and Research

RSS

Nicotine reduction strategy should be an urgent research priority

After a major review of scientific information, six leading tobacco research and policy experts have concluded that a nicotine reduction strategy should be an urgent research priority because of its potential to profoundly reduce the death and disease from tobacco use. Their findings were published today in the journal Tobacco Control.

4 Oct 2010

Fred Hutchinson Center offers research-based tip sheets on breast cancer

Throughout October, National Breast Cancer Awareness Month, experts from Fred Hutchinson Cancer Research Center and its clinical care partner, the Seattle Cancer Care Alliance, are offering a series of weekly research-based tip sheets regarding a variety of topics related to breast cancer, including breast cancer prevention, screening and early detection, treatment, and survivorship.

4 Oct 2010

LSUHSC-S receives $3.9M NIDA grant to develop EMB-001 drug for cocaine dependence

Embera NeuroTherapeutics, Inc., a specialty pharmaceutical company developing novel treatments for addiction and obesity, announced today that the Louisiana State University Health Sciences Center (LSUHSC-S) has received a $3.9 million dollar grant from the National Institute on Drug Abuse (NIDA). The grant will support the next stages of development for Embera's drug candidate EMB-001 to treat cocaine dependence, as well as advance EMB-001 into clinical testing.

1 Oct 2010

GSK supports AHA policy statement on smokeless tobacco products

GlaxoSmithKline (GSK) Consumer Healthcare, a leader in helping smokers quit and the marketer of nicotine replacement therapy (NRT) products, including Nicorette and NicoDerm CQ, supports the findings of the American Heart Association (AHA) policy statement regarding smokeless tobacco products.

28 Sep 2010

European Society of Cardiology to support EuroPRevent Meeting

Workplace wellness programmes play a vital role in preventing cardiovascular disease and stroke. This year's World Heart Day theme is to encourage employers and employees to take simple steps to improve heart-health in the workplace. The European Society of Cardiology is keen to support this theme, which coincides with the upcoming launch of two major initiatives at the next EuroPRevent Meeting in April 2011 in Geneva.

27 Sep 2010

Victorian health report card

Results from the 2008 Victorian Population Health Survey of more than 34,000 people are out. Broadly the picture is not too pleasing with signs of poor health like weight gain and disease. People are eating less fruit and vegetables, but smoking is down and asthma is less prevalent than it was earlier in the decade.

26 Sep 2010

World Heart Federation calls on employers and employees to take responsibility for workplace wellness

Despite the vast majority (91%) of workers believing that it is their employer's responsibility to create a healthy working environment, nearly a third (32%) of employees feels their workplace actually hinders their ability to lead a healthy lifestyle, according to new independent research commissioned by the World Heart Federation and conducted by Opinion Health.

24 Sep 2010

Aradigm Corporation receives $891,000 to purchase common stock shares

Aradigm Corporation today announced that it has received proceeds of approximately $891,000 from the exercise of all of the warrants to purchase an aggregate of 7,527,214 shares of the Company's common stock that were issued in the private placement that closed on June 21, 2010.

23 Sep 2010

Tobacco taxes help kick the habit

The hike in Australia’s tobacco tax has had an expected effect with almost 300,000 people quitting the habit. The tax increase arrived this April with a 25% rise in tobacco taxes. Polls now confirm that the cost of cigarettes are a powerful lever for improving public health, with only 16 per cent of smokers stating they would “continue to smoke at any price”.

23 Sep 2010

NIDA awards GeneGo SBIR grant to develop integrated systems biology platform for nicotine addiction research

GeneGo, Inc., the leading systems biology company, today announced that it has been awarded a grant from the National Institute on Drug Abuse to develop an integrated systems biology platform for research into the causes and treatment of tobacco dependence, nicotine addiction, smoking cessation and tobacco/nicotine withdrawal.

22 Sep 2010

UT MD Anderson Cancer Center aims to reduce tobacco use among at-risk youths in SE Texas

The University of Texas MD Anderson Cancer Center is reaching out to southeast Texas via an interactive, arcade-style video game aimed at reducing tobacco use among at-risk teens and adolescents.

22 Sep 2010

UC researcher receives NIDA’s Avant-Garde Award for cocaine addiction research

A University of Cincinnati (UC) researcher will receive $2.5 million over five years from the National Institute on Drug Abuse (NIDA) to support his work on a potential immunotherapy for cocaine addiction.

22 Sep 2010

NIDA's Avant-Garde Awards support novel approaches for treating tobacco and cocaine addiction

A potential immunotherapy, a new gene therapy, an enzyme inhibitor, and a compound originally isolated from a Chinese herb are among the latest approaches scientists are proposing to treat addiction.

22 Sep 2010

Deep brain stimulation improves OCD symptoms, promotes smoking cessation and weight loss

Electrical stimulation of the brain in a patient with severe obsessive-compulsive disorder (OCD) led to some unanticipated benefits—"effortless" smoking cessation and weight loss, according to a case report in the September issue of Neurosurgery, official journal of the Congress of Neurological Surgeons.

22 Sep 2010

Aradigm Corporation closes transaction with Novo Nordisk A/S

Aradigm Corporation today announced that it closed the transaction contemplated by the previously announced July 30, 2010 Stock Purchase Agreement with Novo Nordisk A/S. At the closing, the Company issued 26 million shares of the Company's common stock to Novo Nordisk A/S in a private placement as consideration for the termination of a promissory note in favor of Novo Nordisk A/S under which approximately $9.1 million was outstanding on July 30, 2010, representing an effective price per share of $0.3505.

20 Sep 2010

Environmental factors are cause of subarachnoid haemorrhage in most cases

The Nordic twin study investigating the heritability of subarachnoid haemorrhage (SAH) suggests that the role of genetic factors underlying the development of SAH is less than previously believed.

20 Sep 2010

Diverse coalition urges California Governor to sign bill to provide health coverage for smoking cessation treatments

A large and unusually diverse of group of interests have come together to urge Governor Schwarzenegger to sign a key health related measure, Senate Bill 220 (Yee, D-San Francisco), which would provide health coverage of smoking cessation treatments and services.

18 Sep 2010

Study examines effects of AEDs on nicotine metabolite levels in smokers

UMDNJ-Robert Wood Johnson Medical School researchers have determined that carbamazepine and oxycarbamazepine, medications commonly used to treat neurologic and psychiatric conditions, increase nicotine metabolism in smokers. As nicotine metabolism increases, cravings for nicotine return more quickly which could lead to more frequent cigarette consumption among individuals who also take these medications.

18 Sep 2010

Aradigm to present Phase 1 studies of inhaled liposomal ciprofloxacin at 2010 ERS Congress

Aradigm Corporation today announced it is presenting data on September 22, 2010, from its Phase 1 studies at the ERS Annual Congress in Barcelona, Spain. The podium presentation elaborates on the pharmacokinetic parameters of ciprofloxacin in the blood and sputum samples that were observed in the healthy volunteers and non-cystic fibrosis bronchiectasis (BE) patients.

17 Sep 2010

Smoking cessation offers favorable economic benefits to California

A new study released today by the American Lung Association, and conducted by researchers at Penn State University, finds that helping smokers quit not only saves lives but also offers favorable economic benefits to California and the nation.

15 Sep 2010

Smoking Cessation News and Research

Nicotine reduction strategy should be an urgent research priority

Fred Hutchinson Center offers research-based tip sheets on breast cancer

LSUHSC-S receives $3.9M NIDA grant to develop EMB-001 drug for cocaine dependence

GSK supports AHA policy statement on smokeless tobacco products

European Society of Cardiology to support EuroPRevent Meeting

Victorian health report card

World Heart Federation calls on employers and employees to take responsibility for workplace wellness

Aradigm Corporation receives $891,000 to purchase common stock shares

Tobacco taxes help kick the habit

NIDA awards GeneGo SBIR grant to develop integrated systems biology platform for nicotine addiction research

UT MD Anderson Cancer Center aims to reduce tobacco use among at-risk youths in SE Texas

UC researcher receives NIDA’s Avant-Garde Award for cocaine addiction research

NIDA's Avant-Garde Awards support novel approaches for treating tobacco and cocaine addiction

Deep brain stimulation improves OCD symptoms, promotes smoking cessation and weight loss

Aradigm Corporation closes transaction with Novo Nordisk A/S

Environmental factors are cause of subarachnoid haemorrhage in most cases

Diverse coalition urges California Governor to sign bill to provide health coverage for smoking cessation treatments

Study examines effects of AEDs on nicotine metabolite levels in smokers

Aradigm to present Phase 1 studies of inhaled liposomal ciprofloxacin at 2010 ERS Congress

Smoking cessation offers favorable economic benefits to California

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News